Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinomaShigeyuki Ozawa(Zero to Three), Ryu‐Ichiro Hata(Kanagawa Dental University)Cancer ScienceJuly 10, 200910.1111/j.1349-7006.2009.01281.xCited by 44SaveCiteExport RISWatch citationsRelated PapersSuppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice|Scientific Reports|2015|44